![Nova Law Review](/assets/md5images/20b943b13ed61efa46785fb9bb434b0f.png)
Recommended Citation
Seamon, Matthew J.
(2010)
"Antitrust and the Biopharmaceutical Industry: Lessons from Hatch-Waxman and an Early Evaluation of the Biologics Price Competition and Innovation Act of 2009,"
Nova Law Review: Vol. 34:
Iss.
3, Article 12.
Available at:
https://nsuworks.nova.edu/nlr/vol34/iss3/12